LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| BT-20 | XL147 | 0.1061 |
| BT-20 | XMD11-50 | 0.2999 |
| BT-20 | XMD11-85h | 0.1040 |
| BT-20 | XMD16-144 | 0.7901 |
| BT-20 | Y39983 | 0.1415 |
| BT-20 | YM 201636 | 0.2327 |
| BT-20 | ZSTK474 | 0.5547 |
| Hs 578T | Seliciclib | 0.0580 |
| Hs 578T | A443654 | 1.0238 |
| Hs 578T | Afatinib | 0.1881 |
| Hs 578T | AT-7519 | 0.9168 |
| Hs 578T | AZD 5438 | 0.7596 |
| Hs 578T | AZD-6482 | 0.2279 |
| Hs 578T | AZD7762 | 1.0164 |
| Hs 578T | AZD8055 | 0.8649 |
| Hs 578T | AZD8330 | 0.7859 |
| Hs 578T | Barasertib | 0.7178 |
| Hs 578T | Dactolisib | 0.8502 |
| Hs 578T | BI-2536 | 1.0846 |
| Hs 578T | SNS-032 | 1.0405 |
| Hs 578T | BMS345541 | 0.1964 |
| Hs 578T | Brivanib | 0.0700 |
| Hs 578T | Buparlisib | 0.6230 |
| Hs 578T | BX-912 | 0.4836 |
| Hs 578T | Alpelisib | 0.1704 |